Sheng-Yung Chang

Title: Innovations of Sheng-Yung Chang

Introduction

Sheng-Yung Chang is a notable inventor based in Oakland, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of methods for obtaining N-terminal methionine-free proteins. With a total of 3 patents to his name, Chang's work has implications for various applications in protein engineering.

Latest Patents

Chang's latest patents include innovative methods utilizing a novel enzyme known as E. coli methionine aminopeptidase. These methods are designed to produce N-terminal methionine-free proteins either in vitro or in vivo. For in vivo applications, plasmid-borne DNA encoding the peptidase is transformed into a bacterial host, which subsequently produces the desired protein. This approach represents a significant advancement in the field of protein synthesis.

Career Highlights

Throughout his career, Sheng-Yung Chang has been associated with Cetus Corporation, where he has furthered his research and development efforts. His work has not only contributed to the scientific community but has also paved the way for practical applications in biotechnology.

Collaborations

Chang has collaborated with esteemed colleagues such as Arie Ben-Bassat and Keith A. Bauer. These partnerships have enhanced the scope and impact of his research, leading to innovative solutions in the field.

Conclusion

Sheng-Yung Chang's contributions to biotechnology through his patents and collaborations highlight his role as a significant inventor in the industry. His innovative methods for protein synthesis continue to influence research and applications in the field.